1,2-distearoylphosphatidylethanolamine has been researched along with Cancer of Lung in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (88.89) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, J; Li, C; Liu, Y; Wang, L; Wang, Y; Zhao, J; Zhou, Y | 1 |
| Cheng, Y; Cui, H; Liu, DZ; Liu, M; Mei, QB; Ye, WL; Zhang, BL; Zhao, YP; Zhou, SY | 1 |
| Harrison, RG; Krais, JJ; Neves, LF; Ramesh, R; Resasco, DE; Van Rite, BD | 1 |
| Jain, AK; Jain, N; Mishra, DK; Rajoriya, V; Sahu, PK | 1 |
| Meng, H; Xu, Y | 1 |
| Cao, J; Gu, Z; He, B; He, X; Jiang, L; Li, L; Pan, W; Yi, Q | 1 |
| Jia, X; Song, J; Wei, P; Yan, H; Zhang, Z | 1 |
| Gill, KK; Kaddoumi, A; Nazzal, S | 1 |
| Benazzouz, F; Cordobes, MD; de Beco, V; Moretti, JL; Starzec, A | 1 |
9 other study(ies) available for 1,2-distearoylphosphatidylethanolamine and Cancer of Lung
| Article | Year |
|---|---|
In vitro and in vivo evaluation of targeting tumor with folate-based amphiphilic multifunctional stabilizer for resveratrol nanosuspensions.
Topics: A549 Cells; Animals; Antineoplastic Agents, Phytogenic; Cell Survival; Drug Delivery Systems; Drug Stability; Folic Acid; Humans; Lung Neoplasms; Mice, Inbred BALB C; Mice, Nude; Microscopy, Electron; Nanoparticles; Phosphatidylethanolamines; Polyethylene Glycols; Resveratrol; Stilbenes; Suspensions; Xenograft Model Antitumor Assays | 2017 |
Bone metastasis target redox-responsive micell for the treatment of lung cancer bone metastasis and anti-bone resorption.
Topics: A549 Cells; Animals; Bone Neoplasms; Bone Resorption; Cell Proliferation; Doxorubicin; Female; Humans; Hydrophobic and Hydrophilic Interactions; Lung Neoplasms; Mice; Mice, Nude; Micelles; Molecular Targeted Therapy; Oxidation-Reduction; Phosphatidylethanolamines; Tissue Distribution | 2018 |
Targeting single-walled carbon nanotubes for the treatment of breast cancer using photothermal therapy.
Topics: Animals; Annexin A5; Biotinylation; Cell Line, Tumor; Cell Proliferation; Cell Survival; Endothelial Cells; Female; Fluorescein-5-isothiocyanate; Humans; Hyperthermia, Induced; Lung Neoplasms; Maleimides; Mammary Neoplasms, Animal; Mice; Mice, Inbred BALB C; Microscopy, Atomic Force; Microscopy, Fluorescence; Nanotubes, Carbon; Phosphatidylethanolamines; Phototherapy; Polyethylene Glycols; Recombinant Proteins; Spectroscopy, Near-Infrared; Staining and Labeling; Suspensions | 2013 |
Mannosylated solid lipid nanoparticles for lung-targeted delivery of Paclitaxel.
Topics: Absorption, Physiological; Animals; Antineoplastic Agents, Phytogenic; Biological Availability; Cell Line, Tumor; Drug Compounding; Drug Delivery Systems; Drug Liberation; Drug Stability; Drug Storage; Humans; Lung Neoplasms; Male; Mannose; Nanoparticles; Paclitaxel; Particle Size; Phosphatidylethanolamines; Pulmonary Alveoli; Rats; Surface Properties; Tissue Distribution; Triglycerides; Xenograft Model Antitumor Assays | 2015 |
Paclitaxel-loaded stealth liposomes: Development, characterization, pharmacokinetics, and biodistribution.
Topics: Animals; Antineoplastic Agents, Phytogenic; Area Under Curve; Carcinoma; Cell Line, Tumor; Cholesterol; Drug Compounding; Drug Liberation; Half-Life; Humans; Injections, Intravenous; Liposomes; Liver; Lung Neoplasms; Mice; Paclitaxel; Phosphatidylcholines; Phosphatidylethanolamines; Polyethylene Glycols; Rats, Sprague-Dawley; Spleen; Tissue Distribution; Xenograft Model Antitumor Assays | 2016 |
Overcoming drug-resistant lung cancer by paclitaxel loaded dual-functional liposomes with mitochondria targeting and pH-response.
Topics: Amino Acid Sequence; Animals; Antineoplastic Agents; Apoptosis; Caspase 9; Cell Line, Tumor; Cytochromes c; Drug Delivery Systems; Drug Resistance, Neoplasm; Female; Humans; Liposomes; Lung; Lung Neoplasms; Mice, Inbred BALB C; Mice, Nude; Mitochondria; Molecular Sequence Data; Paclitaxel; Peptides; Phosphatidylethanolamines; Protons | 2015 |
Enhanced anticancer activity in vitro and in vivo of luteolin incorporated into long-circulating micelles based on DSPE-PEG2000 and TPGS.
Topics: A549 Cells; alpha-Tocopherol; Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Chemistry, Pharmaceutical; Drug Carriers; Drug Delivery Systems; Drug Liberation; Lung Neoplasms; Luteolin; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Micelles; Particle Size; Phosphatidylethanolamines; Polyethylene Glycols; Vitamin E | 2016 |
Mixed micelles of PEG(2000)-DSPE and vitamin-E TPGS for concurrent delivery of paclitaxel and parthenolide: enhanced chemosenstization and antitumor efficacy against non-small cell lung cancer (NSCLC) cell lines.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Survival; Drug Carriers; Humans; Inhibitory Concentration 50; Lung Neoplasms; Magnetic Resonance Spectroscopy; Micelles; Paclitaxel; Particle Size; Phosphatidylethanolamines; Polyethylene Glycols; Sesquiterpenes; Vitamin E | 2012 |
Uptake of liposome-encapsulated 99Tcm-MIBI by sensitive and multidrug-resistant tumour cell lines.
Topics: Adenocarcinoma; Biological Transport; Breast Neoplasms; Carcinoma, Small Cell; Cholesterol; Drug Resistance, Multiple; Female; Humans; Kinetics; Liposomes; Lung Neoplasms; Mouth Neoplasms; Phosphatidylcholines; Phosphatidylethanolamines; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tumor Cells, Cultured | 1999 |